Patents by Inventor France Pietri-Rouxel

France Pietri-Rouxel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINED THERAPY FOR MUSCULAR DISEASES
    Publication number: 20220387624
    Abstract: The present invention relates to the treatment of muscular diseases.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 8, 2022
    Inventors: France PIETRI-ROUXEL, Sestina FALCONE
  • COMPOSITIONS FOR THE TREATMENT OF SARCOPENIA OR DISUSE ATROPHY
    Publication number: 20210275639
    Abstract: The present invention relates to a substance that activates the GDF5 pathway, for use in a method for the treatment of age-related sarcopenia or disuse atrophy.
    Type: Application
    Filed: July 19, 2019
    Publication date: September 9, 2021
    Inventors: France PIETRI-ROUXEL, Sestina FALCONE
  • Effective gene therapy tools for dystrophin exon 53 skipping
    Patent number: 10752898
    Abstract: The invention relates to a recombinant adeno-associated viral vector (rAAV) comprising a sequence encoding an antisense oligonucleotide (AON) directed against a segment of at least 33 bases from the +30 to +69 region of exon 53 of the pre-messenger RNA (pre-mRNA) of dystrophin, advantageously of human origin, and to the use thereof as a drug, in particular for the treatment of Duchenne muscular dystrophy (DMD).
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: August 25, 2020
    Assignee: GENETHON
    Inventors: France Pietri-Rouxel, Virginie Francois
  • EFFECTIVE GENE THERAPY TOOLS FOR DYSTROPHIN EXON 53 SKIPPING
    Publication number: 20180362980
    Abstract: The invention relates to a recombinant adeno-associated viral vector (rAAV) comprising a sequence encoding an antisense oligonucleotide (AON) directed against a segment of at least 33 bases from the +30 to +69 region of exon 53 of the pre-messenger RNA (pre-mRNA) of dystrophin, advantageously of human origin, and to the use thereof as a drug, in particular for the treatment of Duchenne muscular dystrophy (DMD).
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Inventors: France PIETRI-ROUXEL, Virginie FRANCOIS
  • Aryloxypropanolamine derivatives, method of preparation and applications thereof
    Patent number: 6890955
    Abstract: The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: May 10, 2005
    Assignee: Virbac SA
    Inventors: Ahmed El Hadri, Philippe Archimbault, Gérard Leclerc, Arthur Donny Strosberg, France Pietri-Rouxel
  • Aryloxypropanolamine derivatives, method of preparation and applications thereof
    Publication number: 20030158259
    Abstract: The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive. These derivatives comply with the general formula (I) in which R2 represents one of the following groups: —CH2—, —CH2—CH2, —CH(CH3)—CH2—, —C(CH3)═CH—, —C(CH3)2—CH2— or a bond; Q represents: (i) a phenyl radical 3,4-disubstituted alkylene dioxy determining with the phenyl radical, a non-substituted benzodioxane unit, a non-substituted benzodioxol unit, or a 2-substituted benzodioxol unit, (ii) a phenyl radical 3 and/or 4-substituted, by a O—(CH2)x—COOR5 group, (iii) a condensed polycyclic hydrocarbon comprising at least two condensed cycles, (iv) a cyclic hydrocarbon system, optionally cross-linked, and constituting a cycloalkane comprising 1, 2 or 3 cycles.
    Type: Application
    Filed: January 3, 2003
    Publication date: August 21, 2003
    Applicant: VIRBAC SA
    Inventors: Philippe Archimbault, Gerard Leclerc, Arthur Donny Strosberg, France Pietri-Rouxel